Skip to content

Study of microRNAs in the Evolution of Carotid Plaque. Physiopathological and Therapeutic Interest

Study of microRNAs in the Evolution of Carotid Plaque. Physiopathological and Therapeutic Interest

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03149406
Enrollment
30
Registered
2017-05-11
Start date
2012-12-26
Completion date
2015-12-26
Last updated
2026-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carotid Plaque, miRNAs

Brief summary

Carotid stenosis of atherosclerotic origin may be responsible for stroke, which is one of the most important causes of morbidity and mortality in the Western world

Detailed description

Carotid stenosis of atherosclerotic origin may be responsible for stroke, which is one of the most important causes of morbidity and mortality in the Western world. The constitution of the atheroma plaque is linked to the deregulation of several biological phenomena, including angiogenesis, adipogenesis, inflammatory response, lipid metabolism and oxidative stress. In addition to its anatomical and physiological characteristics, the notion of plate stability is of paramount importance for clinical implications. This stability depends largely on the biological composition of the plate. A vulnerable or unstable plaque often has a large lipid body consisting of foam cells (macrophages laden with oxidized LDL) with a thin fibrous screed consisting of smooth muscle cells (CML), collagen fibers and extracellular matrix. This plaque is also made up of numerous inflammatory cells including macrophages, rich vascularization and intraplate hemorrhage. Although the cell composition of the unstable plate is still relatively established, its molecular analysis remains little known. The benefit of carotid surgery in asymptomatic patients with stenosis greater than 70% is increasingly controversial given the moderate risk of spontaneous stroke under optimal medical treatment. This annual average risk is less than 5%. Thus, the discovery of an original and innovative biomarker, predictive of plate rupture, would define the patients most at risk, who benefit most from this surgery.

Interventions

OTHERComparing the expression of miRNAs

by PCR, in symptomatic and asymptomatic carotid plaques.

Sponsors

Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Any adult with a carotid thrombo endarterectomy, * affiliated to a social security scheme, * informed of the study and not opposed to it.

Exclusion criteria

* Any person benefiting from an iterative carotid surgery, * or refusing to participate in the study, * or not being able to express its consent.

Design outcomes

Primary

MeasureTime frameDescription
Analysis of the miRNAs3 yearsby PCR of the composition of the atheroma plaque

Countries

France

Contacts

PRINCIPAL_INVESTIGATORThierry REIX, PhD

CHU AMIENS-PICARDIE

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 25, 2026